Jan 9 2026 - Heron Therapeutics Announces Preliminary, Unaudited Q4 and Full-Year 2025 Net...
Dec 4 2025 - Heron Therapeutics Announces Inclusion of APONVIE® (aprepitant) Injectable...
Nov 4 2025 - Heron Therapeutics Announces Q3 2025 Financial Results and Highlights Commercial...
Oct 29 2025 - Heron Therapeutics Announces Appointment of Thomas Cusack to Board of Directors...